Nicola Cadei
Director/Board Member at BIOTON S.A.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Adam Tomasz Polonek | M | 47 | 18 years | |
| Jolanta Lis | F | - | 7 years | |
| Dariusz Roman Trzeciak | M | 56 | 5 years | |
| Ramesh Rajentheran | M | - | 5 years | |
| Jia Li | M | - | 2 years | |
| Tomasz Siembida | M | - | 2 years | |
| Valery Yeo | F | - | 2 years | |
| Malgorzata Masierek | F | - | 16 years | |
| Dariusz Gurtowski | M | - | - | |
| Katarzyna Stalinska | F | - | 6 years | |
| Kamila Musnicka | F | 44 | 7 years | |
| Michal Deptuch | M | - | 25 years | |
| Jeremy Launders | M | - | 4 years | |
| Marek Dziki | M | 61 |
Pharmatex Italia SRL
 Pharmatex Italia SRL Pharmaceuticals: OtherHealth Technology Part of BIOTON SA, Pharmatex Italia SRL engages in pharmaceuticals production. The company is based in Milan, Italy. The Italian company was founded in 1977. Nicola Cadei has been the CEO of the company since 2016. Pharmatex Italia was acquired by BIOTON SA on June 08, 2006 for $6.39 million. | - |
| Vaidyanathan Viswanath | M | 62 | 2 years | |
| Anna Grabowska | F | - | 6 years | |
| Giuseppe Simoni | M | 80 |
University of Milan
| 36 years |
| Ju Bo Liu | M | 51 | 2 years | |
| Ewelina Romanska | F | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sonia Maria Poli | M | 59 |
University of Milan
| 4 years |
| Carola Rita della Porta | F | 59 |
University of Milan
| 9 years |
| Maria Elisa D'Amico | F | - |
University of Milan
| 5 years |
| Luca Maria Rovere | M | - |
University of Milan
| 6 years |
| Giulia Cavalli | F | - |
AstraZeneca SpA
 AstraZeneca SpA Pharmaceuticals: MajorHealth Technology AstraZeneca SpA engages in the production and distribution of pharmaceutical drugs and medicines. Its products specialize in the treatment and therapies for cardiovascular and metabolic, oncology, and respiratory inflammation, and autoimmunity diseases. The company was founded in April 1999 is headquartered in Basiglio, Italy. | - |
| Michele Garufi | M | 70 |
University of Milan
| 4 years |
| Marco Claudio Grillo | M | 55 |
University of Milan
| 4 years |
| Luigi Francesco Gozzini | M | 57 |
University of Milan
| 4 years |
| Michael Moshe Livian | M | - |
University of Milan
| 5 years |
| Annalisa Matilde Elena Barbera | F | 54 |
University of Milan
| 3 years |
| Roberta Forzanini | F | 59 |
University of Milan
| 3 years |
| Vittoria Giustiniani | F | 60 |
University of Milan
| 3 years |
| Paola Casali | F | 56 |
University of Milan
| 3 years |
| Alberto Ferdinando Toffoletto | M | 63 |
University of Milan
| 3 years |
| Luigi Barni | M | 61 |
University of Milan
| 3 years |
| Marco Mortali | M | 66 |
University of Milan
| 4 years |
| Umberto Zannier | M | - |
University of Milan
| 1 years |
| Massimo Sgrelli | M | - |
University of Milan
| 6 years |
| Stefano Bertola | M | 55 |
University of Milan
| 4 years |
| Danilo Penati | M | 60 |
University of Milan
| 4 years |
| Matteo Bonelli | M | 55 |
University of Milan
| 3 years |
| Ilaria Ambrosella Landonio | M | - |
University of Milan
| 3 years |
| Eleonora Olivieri | F | 55 |
University of Milan
| 4 years |
| Ferrante Enriques | M | - |
University of Milan
| 8 years |
| Roberto Franzo | M | 59 |
University of Milan
| 3 years |
| Andrea Cavallotti | M | - |
University of Milan
| 3 years |
| Silvia Restelli | F | - |
University of Milan
| 4 years |
| Maria Grazia Filippini | F | 59 |
University of Milan
| 4 years |
| Roberto Leonardi | M | - |
University of Milan
| 4 years |
| Piergiuseppe Caldana | M | 60 |
University of Milan
| 4 years |
| Elena Angela Carpani | F | 56 |
University of Milan
| 4 years |
| Raffaele Sabia | M | - |
AstraZeneca SpA
AstraZeneca SpA Pharmaceuticals: MajorHealth Technology AstraZeneca SpA engages in the production and distribution of pharmaceutical drugs and medicines. Its products specialize in the treatment and therapies for cardiovascular and metabolic, oncology, and respiratory inflammation, and autoimmunity diseases. The company was founded in April 1999 is headquartered in Basiglio, Italy. | - |
| Jean Pierre Seveke | M | 62 |
University of Milan
| 4 years |
| Dario Moresco | M | 61 |
University of Milan
| 3 years |
| Roberto Lancellotti | M | 59 |
University of Milan
| 4 years |
| Egidio Cozzi | M | 57 |
University of Milan
| 4 years |
| Daniele Conti | M | 60 |
University of Milan
| 4 years |
| Corrado Castellucci | M | 65 |
AstraZeneca SpA
AstraZeneca SpA Pharmaceuticals: MajorHealth Technology AstraZeneca SpA engages in the production and distribution of pharmaceutical drugs and medicines. Its products specialize in the treatment and therapies for cardiovascular and metabolic, oncology, and respiratory inflammation, and autoimmunity diseases. The company was founded in April 1999 is headquartered in Basiglio, Italy. | - |
| Carlo Gandolfo Cerami | M | 59 |
University of Milan
| 4 years |
| Robert Leslie Holland | M | 69 |
AstraZeneca SpA
AstraZeneca SpA Pharmaceuticals: MajorHealth Technology AstraZeneca SpA engages in the production and distribution of pharmaceutical drugs and medicines. Its products specialize in the treatment and therapies for cardiovascular and metabolic, oncology, and respiratory inflammation, and autoimmunity diseases. The company was founded in April 1999 is headquartered in Basiglio, Italy. | 7 years |
| Paolo Melloni | M | 63 |
University of Milan
| 2 years |
| Nicolò Romani | M | 57 |
University of Milan
| 4 years |
| Sandro Ferrari | M | - |
University of Milan
| 4 years |
| Nicla Picchi | F | 63 |
University of Milan
| 3 years |
| Andrea Costa | M | 64 |
University of Milan
| 4 years |
| Luca Alippi | M | 61 |
University of Milan
| 4 years |
| Sergio Tamborini | M | 65 |
University of Milan
| 4 years |
| Giacomo Foglia | M | 61 |
University of Milan
| 4 years |
| Alessandro de Carli | M | - |
University of Milan
| 4 years |
| Alvise Sagramoso | M | 68 |
University of Milan
| 4 years |
| Alberta Figari | F | 60 |
University of Milan
| 3 years |
| Carlo Pavesi | M | 60 |
University of Milan
| 3 years |
| Andrea Rabusin | M | - |
University of Milan
| 4 years |
| Alessandra della Porta | F | 60 |
University of Milan
| 3 years |
| Max E. Link | M | 84 |
Mipharm SpA
 Mipharm SpA Pharmaceuticals: MajorHealth Technology Mipharm SpA manufactures specialty pharmaceuticals and generic drugs. It operates as a third party manufacturing site for various pharmaceutical brands as well as offers integrated services such as packagaing, research, and development. The company was founded by Giuseppe G. Miglio in January 1998 and is headquartered in Milan, Italy. | - |
| Filippo Gazzola | M | 60 |
University of Milan
| 3 years |
| Gian Paolo Rizzardi | M | - |
University of Milan
| 3 years |
| Stefano Pareglio | M | 61 |
University of Milan
| 4 years |
| Andrea Gambirasio | M | 56 |
University of Milan
| 4 years |
| Giorgio Mosconi | M | 63 |
University of Milan
| 3 years |
| Marco Guerra | M | - |
University of Milan
| 4 years |
| Stefano Giordani | M | - |
University of Milan
| 4 years |
| Stefano Zonca | M | 59 |
University of Milan
| 21 years |
| Andrea Zaglio | M | 57 |
University of Milan
| 1 years |
| Francesca Rasetti | M | 58 |
University of Milan
| 4 years |
| Roberto Spada | M | 60 |
University of Milan
| 3 years |
| Roberto Mazzei | M | 62 |
University of Milan
| 18 years |
| Claudio Tatozzi | M | 55 |
University of Milan
| 3 years |
| Valerio Verderio | M | - |
University of Milan
| 4 years |
| Barbara Masella | F | 59 |
University of Milan
| 4 years |
| Mario Notari | M | 59 |
University of Milan
| 3 years |
| Anna Chiara Svelto | F | 55 |
University of Milan
| 3 years |
| Paolo Lecchi | M | - |
University of Milan
| 3 years |
| Alessandro Malacart | M | 63 |
University of Milan
| 5 years |
| Stefano Gardi | M | - |
University of Milan
| 6 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Italy | 77 | 81.91% |
| Poland | 17 | 18.09% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Nicola Cadei
- Personal Network
